Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Oxfendazole (Toward the Treatment of Neurocysticercosis)

NCT01584362 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.

NCT NCT01584362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01584362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Oxfendazole (Toward the Treatment of Neurocysticercosis)
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Phase
Phase 1
Overall status
Withdrawn
Start date
August 31, 2016
Completion date
August 31, 2016
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tenia solium infection